AR, N., S, S., AN, H., L, A., P, S., JC, A., . . . R, R. (2026). Therapeutic Drug Monitoring for Improving Tuberculosis Treatment Outcomes: A Scoping Review of Clinical Studies. Clinical pharmacokinetics, 65(2), 169. https://doi.org/10.1007/s40262-025-01609-x
Chicago Style (17th ed.) CitationAR, Noeriman, Sumarheni S, Hasanah AN, Apriani L, Santoso P, Alffenaar JC, Gafar F, and Ruslami R. "Therapeutic Drug Monitoring for Improving Tuberculosis Treatment Outcomes: A Scoping Review of Clinical Studies." Clinical Pharmacokinetics 65, no. 2 (2026): 169. https://doi.org/10.1007/s40262-025-01609-x.
MLA (9th ed.) CitationAR, Noeriman, et al. "Therapeutic Drug Monitoring for Improving Tuberculosis Treatment Outcomes: A Scoping Review of Clinical Studies." Clinical Pharmacokinetics, vol. 65, no. 2, 2026, p. 169, https://doi.org/10.1007/s40262-025-01609-x.